Stay updated on Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page.

Latest updates to the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study information regarding the safety and efficacy of nivolumab combined with radiotherapy for unresectable recurrent gastric cancer, and the addition of a new version revision. The principal investigator's name, Koji Kono, remains unchanged.SummaryDifference29%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page.